glp 1 agonist drugs mechanism of action Mechanisms and Therapeutic Application of Glucagon-like Peptide-1 Drug mechanism of action of

Is GLP-1 microdosing safe

This DSIP nasal spray is supplied for in-vitro laboratory research, is not intended for human or veterinary use, is not a drug, supplement or sleep aid, and has not been evaluated by the FDA for the research-chemical context

Studies examining ovariectomized, hormone-primed female rats showed: Dramatic increases in solicitation behaviors (hopping, darting, ear-wiggling) at doses of 100-200 mcg/kg No effects on consummatory behaviors such as lordosis Selective enhancement of proceptive (desire-related) behaviors without affecting receptivity Effects mediated through the medial preoptic area, as direct mPOA injections replicated systemic effects These findings established PT-141 as the first pharmacological agent demonstrating selective appetitive sexual behavior enhancement in preclinical models

Perform a patch test and monitor for any adverse reactions before applying the serum to sensitive areas